Laboratory Corp. (LH) Misses Q1 EPS by 7c; Boosts FY14 EPS Outlook

Laboratory Corp. (NYSE: LH) reported Q1 EPS of $1.51, $0.07 worse than the analyst estimate of $1.58. Revenue for the quarter came in at $1.43 billion versus the consensus estimate of $1.45 billion.

Laboratory Corp. sees FY2014 EPS of $6.40-$6.70, versus prior guidance of $6.35-$6.65 and the consensus of $6.65.

For earnings history and earnings-related data on Laboratory Corp. (LH) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance